F-CRIN, created in 2012, is the single contact point facilitating the participation of France in clinical studies. F-CRIN unites the major academic and commercial stakeholders in clinical research in France, including clinical research and innovation departments in university hospitals (Direction de la Recherche Clinique et de l'Innovation –DRCI), clinical investigation centres (Centre d'Investigation Clinique –CIC) and interregional groups for clinical research and innovation (Groupement Interrégional de Recherche Clinique et d'Innovation –GIRCI).
F-CRIN enables multinational or multicentre, investigator-driven, clinical trials and early phase proof-of-concept studies. Clinical trial support is provided through F-CRIN by the EUCLID and PARTNERS platforms of professional services. These platforms have expertise in the full spectrum of clinical trial services from seeking funding, through design, approval and logistics to data analysis and reporting.
F-CRIN also maintains connections and collaborations with networks specialised in specific diseases or areas of medicine including cardiology (FACT), nutrition (FORCE), inflammatory disease (IMIDIATE), cardiorenal diseases (INI-CRCT), thrombosis (INNOVTE), vaccinology (I-REIVAC), Parkinson’s disease (NS-PARK), and sepsis (TRIGGERSEP). These networks offer expertise and collaboration opportunities in clinical trial aspects related to this fields.
Follow F-CRIN on Twitter: